These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Superoxide dismutase and catalase activity in tracheobronchial secretions after surfactant treatment of newborn infants with respiratory distress syndrome]. Schröder A; Herting E; Speer CP Z Geburtshilfe Neonatol; 1999; 203(5):201-6. PubMed ID: 10596413 [TBL] [Abstract][Full Text] [Related]
3. Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration. Chen CM; Chang CH; Chao CH; Wang MH; Yeh TF Drug Deliv; 2019 Dec; 26(1):604-611. PubMed ID: 31204848 [TBL] [Abstract][Full Text] [Related]
4. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness]. Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392 [TBL] [Abstract][Full Text] [Related]
5. Animal-derived surfactants versus past and current synthetic surfactants: current status. Moya F; Maturana A Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936 [TBL] [Abstract][Full Text] [Related]
6. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Bernhard W; Mottaghian J; Gebert A; Rau GA; von Der HARDT H; Poets CF Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1524-33. PubMed ID: 11029372 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial. Mussavi M; Mirnia K; Asadollahi K Iran J Pediatr; 2016 Oct; 26(5):e5743. PubMed ID: 28203337 [TBL] [Abstract][Full Text] [Related]
9. Biophysical activity of animal-derived exogenous surfactants mixed with rifampicin. Kolomaznik M; Calkovska A; Herting E; Stichtenoth G Adv Exp Med Biol; 2015; 839():31-9. PubMed ID: 25252905 [TBL] [Abstract][Full Text] [Related]
10. Effects of exogenous surfactant and recombinant human copper-zinc superoxide dismutase on oxygen-dependent antimicrobial defenses. Walti H; Nicolas-Robin A; Assous MV; Polla BS; Bachelet M; Davis JM Biol Neonate; 2002 Aug; 82(2):96-102. PubMed ID: 12169831 [TBL] [Abstract][Full Text] [Related]
11. Natural surfactant combined with superoxide dismutase and catalase decreases oxidative lung injury in the preterm lamb. Dani C; Corsini I; Longini M; Burchielli S; Dichiara G; Cantile C; Buonocore G Pediatr Pulmonol; 2014 Sep; 49(9):898-904. PubMed ID: 24339445 [TBL] [Abstract][Full Text] [Related]
12. Choosing a right surfactant for respiratory distress syndrome treatment. Ramanathan R Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858 [TBL] [Abstract][Full Text] [Related]
13. Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Rüdiger M; Tölle A; Meier W; Rüstow B Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L379-83. PubMed ID: 15501950 [TBL] [Abstract][Full Text] [Related]
14. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Seeger W; Grube C; Günther A; Schmidt R Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446 [TBL] [Abstract][Full Text] [Related]
15. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Cummings JJ; Holm BA; Hudak ML; Hudak BB; Ferguson WH; Egan EA Am Rev Respir Dis; 1992 May; 145(5):999-1004. PubMed ID: 1586078 [TBL] [Abstract][Full Text] [Related]
16. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants. Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258 [TBL] [Abstract][Full Text] [Related]
17. Bulk shear viscosities of endogenous and exogenous lung surfactants. King DM; Wang Z; Palmer HJ; Holm BA; Notter RH Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L277-84. PubMed ID: 11792632 [TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome. Hammoud M; Al-Kazmi N; Alshemmiri M; Thalib L; Ranjani VT; Devarajan LV; Elsori H J Matern Fetal Neonatal Med; 2004 Mar; 15(3):167-75. PubMed ID: 15280142 [TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381 [TBL] [Abstract][Full Text] [Related]
20. [Pro- and antioxidant system activity in cervical mucosa]. Sanocka D; Florek E; Klejewski A; Kurpisz M Ginekol Pol; 2002 Jul; 73(7):573-6. PubMed ID: 12369277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]